Responses
Immunotherapy biomarkers
Original research
Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study
Compose a Response to This Article
Other responses
No responses have been published for this article.